Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis

Lignende værker

• Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
  af: Bonadonna, Riccardo C., et al.
  Udgivet: (2021)
• Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: protocol of REALI project
  af: Freemantle, Nick, et al.
  Udgivet: (2020)
• Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: protocol of REALI project
  af: Nick Freemantle, et al.
  Udgivet: (2020-04-01)
• Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment
  af: Javier Escalada, F., et al.
  Udgivet: (2018)
• Comment on “a comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes”
  af: Freemantle, Nick, et al.
  Udgivet: (2019)